Holmes MV

No ORCID on file · 2 papers in corpus · active 2022-2023
2023
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization.
Arthritis & rheumatology (Hoboken, N.J.) ·doi:10.1002/art.42538

ObjectiveIn this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors.MethodsA genome-wide association study meta-analysis was perfo…

2022
Correction: Obesity and risk of female reproductive conditions: A Mendelian randomisation study.
PLoS medicine ·doi:10.1371/journal.pmed.1004095

[This corrects the article DOI: 10.1371/journal.pmed.1003679.].